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G R A P H I C A L A B S T R A C T
A B S T R A C T
The C26 adenocarcinoma tumor line is frequently used to establish peripheral tumors in mice for the study of
cancer cachexia and cancer-related fatigue. Recently, we have noticed a progressive decline in the effects of tumor
growth on our biological and behavioral measures in the tumor-bearing mice. Therefore, we compared effects of
three aliquots of the C26 tumor cell line that differed in storage condition and number of passages on cytokine
secretion, tumor growth, weight loss and fatigue behavior. Three aliquots of the C26 tumor line were selected as
alpha (a), beta (b), and gamma (g). Aliquot a was an original C26 stock line that had been stored at 80 C.
Aliquot b was stored in liquid nitrogen. Aliquot g was taken from aliquot b and passaged three times. The three
aliquots of the C26 tumor line showed differences in IL-6 mRNA and protein secretion in vitro, with aliquot b
showing the greatest IL-6 secretion. These differences were mirrored in vivo. Plasma IL-6 levels were elevated in
all tumor bearing mice but was greatest in group b mice. Carcass weight was decreased in all three tumor groups.
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Brain expression of IL-1b mRNA was greatest in group b and group b demonstrated the greatest decline in
running activity at day 19.
 Storage conditions and number of passages inﬂuence C26 tumor cell secretion of cytokines.
 Variations in C26 aliquots may explain differences observed between laboratories using the same cell line.
 We recommend always storing cell lines in liquid nitrogen and limiting the number of passages before use in
experiments.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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Methods
Cell line
Three aliquots of the colon26 adenocarcinoma (C26) cell line were thawed and maintained in
culture with RPMI 1640 media supplemented with 10% FBS. The three aliquots were termed alpha (a),
beta (b), and gamma (g). The aliquots differed in storage condition and number of passages. Aliquot a
was an original C26 stock line that was stored at 80 C. Aliquot b was stored in liquid nitrogen.
Aliquot g was taken from aliquot b and passaged three times. These conditions were selected as
representations of common lab practice. For example, cell lines may be temporarily stored at 80 C
during re-location and during shipping. Cell lines may also be passaged numerous times during
ongoing experiments. Once conﬂuent, cells were harvested using 0.05% trypsin–EDTA (Gibco), washed
in phosphate buffered saline (PBS), counted using 0.04% trypan blue, and resuspended at 2.5 106
cells/ml in PBS for injection [8]. An aliquot of each cell line was plated in 24 well plates at a density of
100,000 cells/well (n = 4). Media was replaced the following day. After 24 h, media was collected and
frozen at 80 C and RNA was isolated using a tri-reagent protocol.
Mice
Twenty adult (10 weeks) female BALB/c  DBA/2 F1 (CD2F1) mice weighing 20–22 g were obtained
from Charles River Laboratories. Mice were singly housed and maintained at 25 C under a 12 h light
cycle with ad libitum access to food and water. All procedures were performed in accordance with the
National Institute of Health Guidelines for the Care and Use of Laboratory Animals and were approved
by The Ohio State University Institutional Animal Care and Use Committee.
Tumor injection
Groups of ﬁve mice were injected subcutaneously between the scapulae with 5 105 cells from one of
threealiquotsof theC26cell line in0.2 mlof PBS and ﬁvewere injectedwith PBSalone.This tumorcell line
is syngeneic for CD2F1 mice and secretes IL-6 and TNF-a [3] and does not metastasize when injected
subcutaneously [7]. Tumor growth is usually palpable by day 7, weight loss and muscle wasting are
evident afterday 14, and mice become moribund byday 24of tumor-growth. In the present study, all data
collection was completed on day 21 of tumor growth. Mice were euthanized by inhalation of CO2 gas on
day 21 of tumor growth. Blood was withdrawn from the brachial artery. Tumors were dissected and
weighed and the brain was quickly dissected and snap frozen in liquid nitrogen.
IL-6 ELISA
IL-6 levels in the culture medium and plasma were determined using the BD OptEIA Mouse IL-6
ELISA, according to the manufacturer’s instructions (BD Biosciences). Absorbance was read at 450 nm
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using a Synergy HT Plate Reader (Bio-tek instruments). The assay was sensitive to 10 ng/ml IL-6 and
intra-assay coefﬁcients of variation were less than 10%.
Voluntary wheel running activity
Fatigue was modeled as a decline in voluntary wheel running activity (VWRA) in the tumor-bearing
mice [9]. Mice were singly housed and acclimated to a four inch diameter running wheel in the cage
for one week, and baseline measures (week 0) of VWRA were recorded overnight prior to injection of
tumor cells or PBS. Wheels were again placed in the home cages of all mice overnight (6 p.m. to 8 a.m.)
on days 9 and 19 of tumor growth and the total number of turns each night was digitally recorded
(Columbus Instruments, model 0297-004M).
RNA isolation and RT-PCR analysis
RNA was isolated from cells and brain sections using the Tri-Reagent protocol (Sigma) and reverse
transcribed to cDNA using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems).
Quantitative PCR was performed using the Applied Biosystems Assay-on-Demand Gene Expression
protocol. Experimental cDNA was ampliﬁed with an ABI PRISM 7300-sequence detection system
(Applied Biosystems) using real-time PCR and normalized based on reference cDNA (GAPDH). Data were
analyzed with the comparative threshold cycle method. Data are expressed as fold change from control.
Statistical analyses
To ensure a normal distribution, data were analyzed using a Shapiro–Wilk test with the Statistical
Analysis Systems (SAS) statistical software (Cary, NC). To determine signiﬁcance, data were analyzed
using a one-way ANOVA through the General Linear Model procedures of SAS. Differences between
treatment means were evaluated by an F-protected t-test using the Least-Signiﬁcant Difference
procedure of SAS. All data are expressed as treatment means  standard error of the mean (SEM).
Values were considered signiﬁcant at p-values <0.05.
Results
The three different aliquots of C26 cells expressed variable amounts of IL-1b and IL-6 mRNA. All
aliquots secreted IL-6 protein into the culture medium and levels of IL-6 protein were greatest in
media from aliquot b (Fig. 1, p < 0.05). Aliquot a had the lowest levels of IL-6 mRNA and protein
expression (p < 0.05).
One of the three aliquots was injected into ﬁve mice to establish a peripheral tumor. This model is
commonly used in studies of cancer cachexia [1] and cancer-related fatigue [6]. Following 21 days of
Fig. 1. (A) IL-1b and (B) IL-6 mRNA expression in three aliquots of the C26 tumor cell line. (C) IL-6 levels in the media after 24 h.
*p < 0.05 (n = 4).
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Fig. 2. (A) Plasma IL-6 levels in control and a, b, g tumor-bearing mice at 21 days. (B) Carcass weight at day 21. (C) Tumor mass
at day 21. *p < 0.05 from control (n = 5).
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tumor growth, all tumor-bearing mice had elevated levels of IL-6 in the plasma compared to control
animals (Fig. 2A, p < 0.05). Although the data may indicate that mice injected with aliquot b had the
highest amount of plasma IL-6, there were no signiﬁcant differences between groups, most likely due
to the low number of animals used and variability between samples. All tumor-bearing mice showed
signs of cachexia with decreased carcass weight by day 21(Fig. 2B, p < 0.05). There was no difference in
tumor mass between groups (Fig. 2C).
Peripheral tumor growth and systemic inﬂammation increase inﬂammation in the brain which
may inﬂuence fatigue behaviors [6]. Expression of IL-1b mRNA was elevated in the brain of all tumor-
Fig. 3. (A) IL-1b and (B) IL-6 mRNA expression in the brain of control and a, b, g tumor bearing mice at 21 days *p < 0.05. (C)
Wheel running activity of control and a, b, g tumor bearing mice before injection and again at 9 and 19 days after injection.
*p < 0.05 from control (n = 5).
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bearing mice but was highest in mice injected with aliquot b (Fig. 3A, p < 0.05). IL-6 expression in the
brain was only increased in groups b and g (Fig. 3B, p < 0.05). Fatigue, modeled as decreased VWRA,
(WRA) [9] was only detected in group b and g (Fig. 3C, p < 0.05).
Additional information
In conclusion, we found that the three aliquots of the C26 tumor cell line maintained in our
laboratory varied in expression of IL-6 mRNA and protein, and in development of cancer cachexia and
fatigue-like behaviors in the tumor bearing mice. We found distinct and signiﬁcant differences
between aliquots a and b/g, indicating that storage conditions alter the C26 phenotype. The
differences between b and g were modest, suggesting that three passages may alter C26 phenotype.
However, increased passage number may show more striking differences. Overall, our data support
other reports showing that aliquots of the same C26 tumor line can be used for studies of both mild
and severe cachexia [2,5]. These results may also explain variations between study ﬁndings in
different laboratories that use the C26 cell line. However, the cause of this “drift” in tumor phenotype
is not fully understood. One possible mechanism might be genetic or epigenetic changes in gene
expression or cytogenetic/chromosomal rearrangements during freezing or passage of cells [4]. We
recommend always storing cell lines for in vivo tumor studies in liquid nitrogen and also limiting the
number of passages to increase consistency and reliability when using the C26 tumor cell line.
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